The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy

Cell surface–anchored serine proteases in cancer progression and metastasis

(2019) Carly E. Martin et al.   CANCER AND METASTASIS REVIEWS

Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells

(2018) Koji Yamamoto et al.   Oncotarget

PRSS8 suppresses colorectal carcinogenesis and metastasis

(2018) Yonghua Bao et al.   ONCOGENE

Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2–mediated cell-surface localization

(2017) Andrew S. Murray et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Overexpression of Protease Serine 8 Inhibits Glioma Cell Proliferation, Migration, and Invasion via Suppressing the Akt/mTOR Signaling Pathway

(2017) Hu-yin Yang et al.   ONCOLOGY RESEARCH

BCL-XL directly modulates RAS signalling to favour cancer cell stemness

(2017) Sophie de Carné Trécesson et al.   Nature Communications

Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

(2017) Xiaofeng Dai et al.   Journal of Cancer

Type II transmembrane serine proteases as potential targets for cancer therapy

(2016) Andrew S. Murray et al.   BIOLOGICAL CHEMISTRY

The role of type II transmembrane serine protease-mediated signaling in cancer

(2016) Lauren M. Tanabe et al.   FEBS Journal

Tumor suppressor PRSS8 targets Sphk1/S1P/Stat3/Akt signaling in colorectal cancer

(2016) Yonghua Bao et al.   Oncotarget

PRSS8 methylation and its significance in esophageal squamous cell carcinoma

(2016) Yonghua Bao et al.   Oncotarget

Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin

(2015) Stine Friis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling

(2015) Gina L. Zoratti et al.   Nature Communications

PROGgeneV2: enhancements on the existing database

(2015) Chirayu Pankaj Goswami et al.   BMC CANCER

TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition

(2014) Daniel H. Madsen et al.   BIOCHEMICAL JOURNAL

The Membrane-anchored Serine Protease Prostasin (CAP1/PRSS8) Supports Epidermal Development and Postnatal Homeostasis Independent of Its Enzymatic Activity

(2014) Diane E. Peters et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DESC1 and MSPL Activate Influenza A Viruses and Emerging Coronaviruses for Host Cell Entry

(2014) P. Zmora et al.   JOURNAL OF VIROLOGY

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features

(2013) Stine Friis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency

(2012) Guo Wei et al.   CANCER CELL

The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment

(2010) Toni M. Antalis et al.   BIOCHEMICAL JOURNAL

TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor

(2010) Tomio Hashimoto et al.   FEBS Journal

Novel Type II Transmembrane Serine Proteases, MSPL and TMPRSS13, Proteolytically Activate Membrane Fusion Activity of the Hemagglutinin of Highly Pathogenic Avian Influenza Viruses and Induce Their Multicycle Replication

(2010) Y. Okumura et al.   JOURNAL OF VIROLOGY

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis

(2009) Joanna Selzer-Plon et al.   BMC CANCER

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

(2009) Antoinette Hollestelle et al.   BREAST CANCER RESEARCH AND TREATMENT

Type II Transmembrane Serine Proteases

(2009) Thomas H. Bugge et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor

(2009) Mengqian Chen et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Clinical significance of low expression ofProstasinmRNA in human gastric cancer

(2008) Katsuya Sakashita et al.   JOURNAL OF SURGICAL ONCOLOGY

The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase–Prostasin serine protease cascade in cultured epithelial cells

(2007) Mengqian Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

MSPL/TMPRSS13

(2007) Hiroshi Kido   Frontiers in Bioscience-Landmark

Type II transmembrane serine proteases in development and disease

(2007) R SZABO et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY